Filtered By:
Source: Oncology Letters
Cancer: Androgen Independent Prostate Cancer
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4 results found since Jan 2013.
Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
Oncol Lett. 2021 Dec;22(6):831. doi: 10.3892/ol.2021.13092. Epub 2021 Oct 13.ABSTRACTIn clinical samples, the expression of androgen receptor (AR) and of AR splice variant 7 (AR-V7) is higher in castration-resistant prostate cancer (CRPC) compared with that in hormone-sensitive prostate cancer (PCa). However, there are only a few reports on the ratio of the expression levels of AR-V7 to AR (AR-V7/AR) in prostate tissue. The present study evaluated AR-V7/AR expression in various types of human prostate tissues and CRPC cells. Pretreatment prostate tissue samples from patients with benign prostatic hyperplasia (BPH; n=18), G...
Source: Oncology Letters - October 25, 2021 Category: Cancer & Oncology Authors: Yoshitaka Sekine Hiroshi Nakayama Yoshiyuki Miyazawa Seiji Arai Hidekazu Koike Hiroshi Matsui Yasuhiro Shibata Kazuto Ito Kazuhiro Suzuki Source Type: research
